Peter Attia

Physician & Longevity Researcher

Early Medical

Peter Attia is a Canadian-American author and former researcher known for his work in longevity medicine. He is the author of Outlive: The Science and Art of Longevity.

Peter Attia is a physician and longevity researcher focused on evidence-based interventions for extending healthspan—the period of life lived in good health. He founded Early Medical and advocates for a systems-based approach to aging that integrates metabolic health, exercise, nutrition, and sleep optimization.

Mechanism of action

Attia's work is grounded in the view that aging is a modifiable biological process that can be slowed through targeted interventions across multiple domains. His framework emphasizes the interconnection between metabolic function (glucose regulation, lipid metabolism), cardiovascular fitness and muscle preservation through exercise, nutritional strategies tailored to individual physiology, and sleep quality as foundational to all other health outcomes. The underlying premise is that optimizing these factors reduces the risk of age-related diseases (cancer, cardiovascular disease, Alzheimer's disease, type 2 diabetes) rather than extending lifespan alone.

Evidence overview

Note: Specific peer-reviewed publications by Peter Attia are not currently available in the evidence pipeline. However, Attia's work is grounded in a large and growing body of independently conducted research supporting the individual components of his framework. Studies consistently demonstrate that regular exercise (especially resistance and aerobic training) is associated with improved metabolic health, reduced mortality risk, and preservation of muscle mass and cognitive function with age. Nutritional approaches such as lower refined carbohydrate intake and intermittent fasting have shown benefits for glucose control and metabolic flexibility in randomized controlled trials and observational studies, though optimal protocols remain debated. Sleep duration and quality are causally linked to metabolic function, immune health, and mortality in prospective studies. The integration of these interventions into a personalized, systematic approach—as Attia advocates—has not been extensively evaluated in large-scale randomized trials, meaning his specific protocols remain largely based on mechanistic reasoning and clinical observation rather than definitive human outcome data.